ING Group’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,553
Closed -$325K 788
2019
Q2
$325K Buy
5,553
+40
+0.7% +$2.36K 0.01% 636
2019
Q1
$313K Buy
5,513
+31
+0.6% +$1.65K 0.01% 591
2018
Q4
$272K Buy
+5,482
New +$330K 0.01% 609
2018
Q3
Sell
-7,852
Closed -$409K 883
2018
Q2
$409K Buy
7,852
+55
+0.7% +$2.88K 0.01% 520
2018
Q1
$407K Buy
7,797
+106
+1% +$5.38K 0.01% 524
2017
Q4
$450K Buy
7,691
+1,469
+24% +$83.3K 0.01% 525
2017
Q3
$345K Buy
6,222
+58
+0.9% +$3.84K 0.01% 649
2017
Q2
$474K Buy
+6,164
New +$461K 0.01% 508

Other funds holding NUVA

ING Group's NUVA Position: Q3 2019 in Review

ING Group sold out of NuVasive, Inc. (NUVA) in Q3 2019, closing a stake of 5,553 shares — an estimated $325K sold.

ING Group first reported a position in NUVA in Q2 2017 and held it in 8 quarters. The position peaked at $474K in Q2 2017. 262 funds tracked by Wall St. Rank hold NUVA as of Q3 2019.

  • ING Group reported no remaining NuVasive, Inc. position as of Q3 2019 after selling out during the quarter.
  • ING Group sold 5,553 NuVasive, Inc. shares in Q3 2019, an estimated $325K.
  • ING Group first reported a position in NuVasive, Inc. in Q2 2017 and held it in 8 quarters.
  • ING Group's NuVasive, Inc. position peaked at $474K in Q2 2017.
  • 262 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2019.

Based on ING Group's 13F filing for Q3 2019, filed 8 Nov 2019.